Federal Law vs. State Law: Understanding Dispensary Legal Conflicts

The legal status of cannabis in the United States exists in a state of deliberate contradiction — legal under the laws of 38 states for medical use, legal for adult recreational use in 24 states, and simultaneously classified as a Schedule I controlled substance under federal law. That gap between state permission and federal prohibition is not a temporary oversight waiting to be corrected. It is the operating environment for every dispensary in the country, shaping everything from banking access to criminal exposure. Understanding where federal authority ends and state authority begins is foundational to understanding how dispensary licensing requirements and operations actually function.

Definition and scope

Federal cannabis prohibition originates from the Controlled Substances Act (CSA) of 1970, codified at 21 U.S.C. § 801 et seq., which places cannabis — classified as marijuana under that statute — in Schedule I alongside heroin and LSD. Schedule I designation means no accepted medical use, high abuse potential, and no pathway to prescribe under federal law. A physician cannot write a prescription for cannabis; they can only issue a recommendation under state frameworks.

State medical and recreational cannabis programs operate under a different legal theory entirely: they decline to enforce state-level prohibition, but they cannot nullify federal law. The Tenth Amendment to the U.S. Constitution bars the federal government from commandeering state law enforcement resources to enforce federal statutes, which is the structural reason why states can legalize cannabis without federal permission — but also why federal agencies retain independent authority to prosecute.

The scope of this conflict is national. The dispensary state-by-state map illustrates how dramatically state frameworks differ from one another, but every one of them exists beneath the same federal ceiling.

How it works

The coexistence of state legalization and federal prohibition is managed through a combination of prosecutorial discretion, congressional appropriations riders, and regulatory forbearance — not through any formal resolution of the underlying legal conflict.

The mechanism works roughly like this:

1. The Cole Memorandum framework (2013–2018): The Department of Justice issued guidance in 2013 directing federal prosecutors to deprioritize cannabis enforcement in states with robust regulatory frameworks. Attorney General Jeff Sessions rescinded that memo in January 2018, returning enforcement discretion entirely to individual U.S. Attorneys. No binding successor policy exists.

2. The Rohrabacher-Blumenauer Amendment: Congress has annually included an appropriations rider since 2014 prohibiting the Department of Justice from using federal funds to interfere with state medical cannabis programs (Department of Justice Appropriations Act, successive fiscal years). This rider does not apply to recreational programs and must be renewed each fiscal year — it is not a permanent protection.

3. FinCEN Guidance (2014): The Financial Crimes Enforcement Network issued guidance permitting banks to serve cannabis businesses under a suspicious activity report (SAR) filing framework (FinCEN Guidance FIN-2014-G001). This created a narrow pathway for banking, though most major financial institutions still decline cannabis clients, which is why dispensary banking and payments remains structurally constrained.

4. IRS Section 280E: The Internal Revenue Code's Section 280E prohibits businesses trafficking in Schedule I or II substances from deducting ordinary business expenses. Dispensaries pay federal income tax on gross profit rather than net profit, a structural tax penalty that does not apply to any other retail sector. The dispensary taxes page covers the operational consequences of 280E in detail.

Common scenarios

The federal-state conflict surfaces in identifiable patterns across dispensary operations.

Banking and cash: Because cannabis remains federally controlled, most FDIC-insured banks decline accounts from cannabis businesses under Bank Secrecy Act exposure concerns. Dispensaries frequently operate as cash-heavy businesses, creating security risks that feed directly into dispensary security requirements.

Employment and background checks: Dispensary employees may face federal employment consequences. Workers with federally issued security clearances risk clearance suspension for cannabis-related employment, even in fully legal state programs.

Real estate and leases: Landlords who accept cannabis tenants can technically face federal civil asset forfeiture exposure, since the property is being used to facilitate a federal Schedule I offense. This shapes commercial lease negotiations for operators researching how to open a dispensary.

Interstate commerce: Cannabis products cannot legally cross state lines, even between two states where cannabis is fully legal. A dispensary in Oregon cannot import product from California regardless of state law in either jurisdiction. This constraint shapes supply chains and is directly relevant to dispensary inventory management.

Tribal lands: Cannabis operations on federally recognized tribal lands exist in their own jurisdictional complexity. The federal government holds treaty obligations that interact unpredictably with both CSA enforcement and state regulatory frameworks.

Decision boundaries

Distinguishing what state law governs from what federal law governs is not always intuitive. Three structural lines clarify the boundary:

What state law controls: licensing eligibility, product testing standards (dispensary lab testing requirements), possession limits, advertising restrictions, zoning, and the employment of licensed professionals. A state agency can revoke a dispensary license; a state court can adjudicate a licensing dispute.

What federal law controls regardless of state authorization: interstate commerce, federal tax treatment under Section 280E, federal employment consequences, federal contracting eligibility, and prosecution under the CSA if a U.S. Attorney chooses to pursue it. No state law can override these exposures.

What sits in the grey zone: banking access, real estate exposure, tribal jurisdiction, and the fate of pending federal legislation such as the SAFE Banking Act, which has passed the House of Representatives 7 times as of 2023 without advancing through the Senate (Congressional Research Service tracking). The regulatory context for dispensary framework addresses how operators navigate this uncertainty at the operational level.

The core asymmetry is durable: states can create permission, but they cannot create immunity. A dispensary that is fully compliant with every state regulation in a legal cannabis state is still operating in technical violation of federal law. That tension is not a footnote — it is the defining legal fact of the industry.